Growing community of inventors

Kiel, Germany

Susanne Sebens

Average Co-Inventor Count = 11.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Susanne SebensYi Li (2 patents)Susanne SebensGerhard Moldenhauer (2 patents)Susanne SebensPeter Altevogt (2 patents)Susanne SebensUlrich Moebius (2 patents)Susanne SebensDaniela Kelm (2 patents)Susanne SebensAchim Krueger (2 patents)Susanne SebensSandra Luettgau (2 patents)Susanne SebensHeiner Schaefer (2 patents)Susanne SebensFrank Breitling (1 patent)Susanne SebensSandra Lüttgau (3 patents)Susanne SebensFrank Brietling (1 patent)Susanne SebensSilke Baerreiter (1 patent)Susanne SebensSilke Wolterink (1 patent)Susanne SebensUlrich Möbius (1 patent)Susanne SebensHeiner Schäfer (0 patent)Susanne SebensAchim Krüger (0 patent)Susanne SebensSusanne Sebens (2 patents)Yi LiYi Li (23 patents)Gerhard MoldenhauerGerhard Moldenhauer (11 patents)Peter AltevogtPeter Altevogt (8 patents)Ulrich MoebiusUlrich Moebius (7 patents)Daniela KelmDaniela Kelm (4 patents)Achim KruegerAchim Krueger (2 patents)Sandra LuettgauSandra Luettgau (2 patents)Heiner SchaeferHeiner Schaefer (2 patents)Frank BreitlingFrank Breitling (12 patents)Sandra LüttgauSandra Lüttgau (3 patents)Frank BrietlingFrank Brietling (2 patents)Silke BaerreiterSilke Baerreiter (1 patent)Silke WolterinkSilke Wolterink (1 patent)Ulrich MöbiusUlrich Möbius (1 patent)Heiner SchäferHeiner Schäfer (0 patent)Achim KrügerAchim Krüger (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts (2 from 160 patents)

2. Medigene Ag (2 from 48 patents)


2 patents:

1. 9260521 - Treatment of tumors using specific anti-L1 antibody

2. 8580258 - Treatment of tumors using specific anti-L1 antibody

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…